Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Automatic rebalancing can use FIFO or specific share lots to determine gains. This intro contrasts methods and outlines tax effects.
18,554 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
A $250,000 SPIA promises $1,600 a month for life, but it comes with lock-in, fees, and a trade-off between predictabl...
Robinhood Chain has posted $816,000 in gross revenue since its July 1 launch, with 89% going to Robinhood, 10% to Arb...
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
Two unevenly matched tech players—Amplitude and Agilysys—show how top-line growth and margins shape investor expectat...
Trump endorses Mike Lindell as Minnesota governor candidate, highlighting election-security themes and setting up a h...
Asia’s top travel platform Klook aims for Western growth amid a fintech-friendly US landscape. Analysts say U.S. part...
Two market leaders just lit up a golden cross, drawing investor attention to Best Buy and Visa. Here’s a concise read...
The Russell 2000 is on track for its strongest year since 2003, outpacing the S&P 500 as AI infrastructure plays lift...
A tumultuous week for Korea's retail traders, nicknamed 'the ants,' sparked widespread margin calls and a regional ri...
A massive debt issuance reveals where Amazon is headed under Andy Jassy. This article breaks down the implications fo...